Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PE O-22:1/18:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003792 AN006233 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Maple syrup urinary disease University of Colorado Denver LC-MS
ST003792 AN006233 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Metabolic disease University of Colorado Denver LC-MS
ST003694 AN006060 FOLFIRINOX effects on lipidomics in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003637 AN005974 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003222 AN005283 A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 Heart Mouse Ischemia University of Mississippi Medical Center LC-MS
ST002967 AN004875 Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids Cultured cells Human Cancer Ohio State University LC-MS
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002070 AN003375 Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Cultured cells Human Cancer Ohio State University LC-MS
  logo